For research use only. Not for therapeutic Use.
Dorsomorphin(Cat No.:I005212)is a selective inhibitor of AMP-activated protein kinase (AMPK), an essential regulator of cellular energy homeostasis. By inhibiting AMPK, dorsomorphin alters metabolic pathways involved in glucose and lipid metabolism, making it a valuable tool for research in metabolic disorders. It has shown potential in studies related to obesity, diabetes, and cancer, where AMPK’s regulatory role is critical. Additionally, dorsomorphin has been explored for its effects on bone metabolism and development. Its unique mechanism of action provides insights into the complex regulation of cellular energy and metabolic pathways.
Catalog Number | I005212 |
CAS Number | 866405-64-3 |
Synonyms | 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine |
Molecular Formula | C₂₄H₂₅N₅O |
Purity | ≥95% |
Target | AMPK |
Solubility | 10 mM in DMSO (with heating); 5 mM in ethanol (with heating) |
Storage | Store at -20C |
IC50 | 109 nM (Ki for AMPK) |
IUPAC Name | 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine |
InChI | InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2 |
InChIKey | XHBVYDAKJHETMP-UHFFFAOYSA-N |
SMILES | C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3 |
Reference | <p style=/line-height:25px/> |